Clinical formulations
US-2026053930-A1 · Feb 26, 2026 · US
Astellas Inst For Regenerative Medicine holds 100 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 100 |
| Recent patents | 33 |
| First publication | Jan 24, 2017 |
| Latest publication | Feb 26, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026053930-A1 · Feb 26, 2026 · US
US-12558380-B2 · Feb 24, 2026 · US
US-2026043008-A1 · Feb 12, 2026 · US
US-12545945-B2 · Feb 10, 2026 · US
US-12508284-B2 · Dec 30, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026053930-A1 · Feb 26, 2026 · US
US-12558380-B2 · Feb 24, 2026 · US
US-2026043008-A1 · Feb 12, 2026 · US
US-12545945-B2 · Feb 10, 2026 · US
US-12508284-B2 · Dec 30, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 95 |
| Human Necessities | 92 |
| Cross-Sectional Technologies | 19 |
| Physics | 13 |
| Operations & Transport | 2 |
Answers are generated from the same data shown on this page.